Briacell Therapeutics Corp
BCTX9.150USD
+0.070+0.77%
收盘 09/19, 16:00（美东）报价延迟15分钟
60.01M总市值
亏损市盈率 TTM
关于 Briacell Therapeutics Corp 公司
BriaCell Therapeutics Corp. 是一家临床阶段的生物技术公司，致力于开发新型免疫疗法来改变癌症治疗。其 3 期主要候选药物 Bria-IMT 是一种获得专利的、现成的、基于细胞的靶向免疫疗法，可激活患者的免疫系统，专门杀死癌细胞而不会伤害其他细胞。该公司正在推进其 Bria-IMT 靶向免疫疗法与免疫检查点抑制剂 (Retifanlimab) 的联合治疗，以治疗转移性乳腺癌的关键 3 期研究。该公司还在开发个性化的现成免疫疗法 Bria-OTS 和 Bria-OTS+，这为开发针对多种癌症的个性化现成免疫疗法提供了平台技术，以及一种可溶性 CD80 蛋白疗法，它既可以作为免疫系统的刺激剂，也可以作为免疫检查点抑制剂。其管道还包括 Bria-IMT + CPI、Bria-BRES/BRES+、Bria-PROS+、Bria-LUNG+ 和 Bria-MEL+。
公司简介
公司代码BCTX
公司名称Briacell Therapeutics Corp
上市日期Oct 12, 2006
CEODr. William V. Williams, M.D.
员工数量17
证券类型Ordinary Share
年结日Oct 12
公司地址Suite 300 - Bellevue Centre, 235 -15th Street
城市WEST VANCOUVER
上市交易所NASDAQ Capital Market Consolidated
国家Canada
邮编V7T 2X1
电话16049211810
网址https://briacell.com/
公司代码BCTX
上市日期Oct 12, 2006
CEODr. William V. Williams, M.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. William V. Williams, M.D.
Dr. William V. Williams, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
35.30K
+401.29%
Dr. Giuseppe Del Priore, M.D.
Dr. Giuseppe Del Priore, M.D.
Chief Medical Officer
Chief Medical Officer
18.84K
--
Mr. Gadi Levin
Mr. Gadi Levin
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
9.44K
+49573.68%
Dr. Miguel A. Lopez-Lago
Dr. Miguel A. Lopez-Lago
Chief Scientific Officer
Chief Scientific Officer
9.42K
--
Mr. Jamieson Bondarenko
Mr. Jamieson Bondarenko
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
1.08K
+34.79%
Mr. Vaughn C. Embro-pantalony, CPA
Mr. Vaughn C. Embro-pantalony, CPA
Independent Director
Independent Director
119.00
+22.68%
Mr. Martin E. Schmieg, CPA
Mr. Martin E. Schmieg, CPA
Independent Director
Independent Director
--
--
Dr. Rebecca A. Taub, M.D.
Dr. Rebecca A. Taub, M.D.
Independent Director
Independent Director
--
-100.00%
Dr. Jane A. Gross, Ph.D.
Dr. Jane A. Gross, Ph.D.
Independent Director
Independent Director
--
-100.00%
名称
名称/职务
职务
持股
持股变动
Dr. William V. Williams, M.D.
Dr. William V. Williams, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
35.30K
+401.29%
Dr. Giuseppe Del Priore, M.D.
Dr. Giuseppe Del Priore, M.D.
Chief Medical Officer
Chief Medical Officer
18.84K
--
Mr. Gadi Levin
Mr. Gadi Levin
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
9.44K
+49573.68%
Dr. Miguel A. Lopez-Lago
Dr. Miguel A. Lopez-Lago
Chief Scientific Officer
Chief Scientific Officer
9.42K
--
Mr. Jamieson Bondarenko
Mr. Jamieson Bondarenko
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
1.08K
+34.79%
Mr. Vaughn C. Embro-pantalony, CPA
Mr. Vaughn C. Embro-pantalony, CPA
Independent Director
Independent Director
119.00
+22.68%
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 9月6日 周六
更新时间: 9月6日 周六
持股股东
股东类型
持股股东
持股股东
占比
Heights Capital Management, Inc.
5.31%
Iroquois Capital Management, LLC
2.97%
Williams (William V)
1.87%
Del Priore (Giuseppe)
1.00%
L5 Capital Inc.
0.92%
其他
87.92%
持股股东
持股股东
占比
Heights Capital Management, Inc.
5.31%
Iroquois Capital Management, LLC
2.97%
Williams (William V)
1.87%
Del Priore (Giuseppe)
1.00%
L5 Capital Inc.
0.92%
其他
87.92%
股东类型
持股股东
占比
Investment Advisor
5.39%
Individual Investor
3.94%
Hedge Fund
2.97%
Investment Advisor/Hedge Fund
1.26%
Corporation
1.21%
Research Firm
0.03%
其他
85.19%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
65
831.24K
7.95%
-645.60K
2025Q1
68
476.26K
7.27%
-513.92K
2024Q4
65
403.53K
10.88%
-198.25K
2024Q3
64
441.30K
30.40%
+131.88K
2024Q2
63
437.48K
31.09%
+121.43K
2024Q1
62
332.09K
21.52%
-17.16K
2023Q4
67
402.86K
34.69%
+35.57K
2023Q3
74
369.20K
35.11%
-158.11K
2023Q2
84
434.95K
41.59%
-338.84K
2023Q1
83
423.04K
40.96%
-355.97K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Heights Capital Management, Inc.
489.20K
7.46%
+489.20K
--
Apr 24, 2025
Williams (William V)
10.81K
0.16%
+222.00
+2.10%
Dec 09, 2024
L5 Capital Inc.
174.03K
2.65%
+4.50K
+2.65%
Dec 10, 2024
Lynwood Capital Management Inc.
106.52K
1.62%
+1.14K
+1.08%
Mar 31, 2024
Levin (Gadi)
187.00
0%
--
--
Dec 09, 2024
3I Management LLC
91.69K
1.4%
-277.31K
-75.15%
Mar 31, 2025
Copia Fund (Cayman) LP
54.56K
0.83%
+54.56K
--
Dec 29, 2023
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Jan 03, 2025
Merger
15→1
Jan 03, 2025
Merger
15→1
Jan 03, 2025
Merger
15→1
Jan 03, 2025
Merger
15→1
公告日期
类型
比率
Jan 03, 2025
Merger
15→1
Jan 03, 2025
Merger
15→1
Jan 03, 2025
Merger
15→1
Jan 03, 2025
Merger
15→1
